Does DENOSUMAB Cause Therapeutic product effect incomplete? 297 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 297 reports of Therapeutic product effect incomplete have been filed in association with DENOSUMAB (Bilprevda). This represents 0.2% of all adverse event reports for DENOSUMAB.
297
Reports of Therapeutic product effect incomplete with DENOSUMAB
0.2%
of all DENOSUMAB reports
8
Deaths
31
Hospitalizations
How Dangerous Is Therapeutic product effect incomplete From DENOSUMAB?
Of the 297 reports, 8 (2.7%) resulted in death, 31 (10.4%) required hospitalization, and 3 (1.0%) were considered life-threatening.
Is Therapeutic product effect incomplete Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DENOSUMAB. However, 297 reports have been filed with the FAERS database.
What Other Side Effects Does DENOSUMAB Cause?
Off label use (34,612)
Death (16,545)
Osteonecrosis of jaw (8,438)
Arthralgia (5,890)
Pain in extremity (4,541)
Back pain (4,465)
Pain (4,102)
Product storage error (3,621)
Fall (3,322)
Fatigue (3,009)
What Other Drugs Cause Therapeutic product effect incomplete?
ALBUTEROL (8,496)
ADALIMUMAB (6,986)
PREDNISONE (6,709)
METHOTREXATE (6,037)
TOFACITINIB (4,914)
SECUKINUMAB (4,661)
BUDESONIDE\FORMOTEROL (4,392)
TIOTROPIUM (4,327)
MEPOLIZUMAB (4,106)
ETANERCEPT (3,961)
Which DENOSUMAB Alternatives Have Lower Therapeutic product effect incomplete Risk?
DENOSUMAB vs DEOXYCHOLIC ACID
DENOSUMAB vs DEPAKINE CHRONO
DENOSUMAB vs DEPAKOTE
DENOSUMAB vs DEPO-PROVERA
DENOSUMAB vs DERMATOPHAGOIDES FARINAE